Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 14;7(3):586-613.
doi: 10.1021/acsptsci.3c00346. eCollection 2024 Mar 8.

Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers

Rumiana Tenchov  1 , Aparna K Sapra  2 , Janet Sasso  1 , Krittika Ralhan  3 , Anusha Tummala  2 , Norman Azoulay  2 , Qiongqiong Angela Zhou  1
Affiliations
Review

Biomarkers for Early Cancer Detection: A Landscape View of Recent Advancements, Spotlighting Pancreatic and Liver Cancers

Rumiana Tenchov et al. ACS Pharmacol Transl Sci. .

Abstract

Cancer is one of the leading causes of death worldwide. Early cancer detection is critical because it can significantly improve treatment outcomes, thus saving lives, reducing suffering, and lessening psychological and economic burdens. Cancer biomarkers provide varied information about cancer, from early detection of malignancy to decisions on treatment and subsequent monitoring. A large variety of molecular, histologic, radiographic, or physiological entities or features are among the common types of cancer biomarkers. Sizeable recent methodological progress and insights have promoted significant developments in the field of early cancer detection biomarkers. Here we provide an overview of recent advances in the knowledge related to biomolecules and cellular entities used for early cancer detection. We examine data from the CAS Content Collection, the largest human-curated collection of published scientific information, as well as from the biomarker datasets at Excelra, and analyze the publication landscape of recent research. We also discuss the evolution of key concepts and cancer biomarkers development pipelines, with a particular focus on pancreatic and liver cancers, which are known to be remarkably difficult to detect early and to have particularly high morbidity and mortality. The objective of the paper is to provide a broad overview of the evolving landscape of current knowledge on cancer biomarkers and to outline challenges and evaluate growth opportunities, in order to further efforts in solving the problems that remain. The merit of this review stems from the extensive, wide-ranging coverage of the most up-to-date scientific information, allowing unique, unmatched breadth of landscape analysis and in-depth insights.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Similar articles

See all similar articles

Cited by

References

    1. Cancer, Feb 3, 2022. https://www.who.int/news-room/fact-sheets/detail/cancer#:~:text=Cancer%2... (accessed Jul 12, 2023).
    1. Thun M. J.; DeLancey J. O.; Center M. M.; Jemal A.; Ward E. M. The global burden of cancer: priorities for prevention. Carcinogenesis 2010, 31, 100–110. 10.1093/carcin/bgp263. - DOI - PMC - PubMed
    1. Age and Cancer Risk, Mar 5, 2021. https://www.cancer.gov/about-cancer/causes-prevention/risk/age#:~:text=A... (accessed Nov 6, 2021).
    1. Tobore T. O. On the need for the development of a cancer early detection, diagnostic, prognosis, and treatment response system. Future Sci. OA 2020, 6, Fso439.10.2144/fsoa-2019-0028. - DOI - PMC - PubMed
    1. Tappia P. S.; Ramjiawan B. Biomarkers for Early Detection of Cancer: Molecular Aspects. Int. J. Mol. Sci. 2023, 24, 5272.10.3390/ijms24065272. - DOI - PMC - PubMed
  NODES
INTERN 3
twitter 2